Intelligence Platform

Patents

Browse 1,444 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 9228188

Compositions and method for inhibiting hepcidin antimicrobial peptide (HAMP) or HAMP-relat

Alnylam Pharmaceuticals, Inc. · Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9220706

Inhibition of leukemic stem cells by PP2A activating agents

THE UNITED STATES OF AMERICA NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR) · Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9212364

Compositions and methods for inhibiting expression of mutant EGFR gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9206421

Lipid formulated compositions and methods for inhibiting expression of serum amyloid A gen

Alnylam Pharmaceuticals, Inc. · Granted Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9198983

Compositions and methods for inhibiting expression of Mylip/Idol gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9200282

Compositions and methods for inhibiting expression of an RNA from west nile virus

Alnylam Pharmaceuticals, Inc. · Granted Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9198948

Methods of treating depression and other related diseases

Northwestern University · Granted Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9192578

Hot-melt extrusion of modified release multi-particulates

The Board of Regents of the University of Texas System · Granted Tue Nov 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9192683

Methods of treating disease with FGFR1 fusion proteins

Five Prime Therapeutics, Inc. · Granted Tue Nov 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9187516

Compositions and methods for inhibiting expression of a gene from the Ebola virus

The United States of America as represented by the Secretary of the Army · Granted Tue Nov 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9186340

Ischemia/reperfusion protection compositions and methods of using

Regents of the University of Minnesota · Granted Tue Nov 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9181306

Insertion of foreign genes in rubella virus and their stable expression in a live, attenua

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9173957

FGFR2 fusion proteins comprising C-terminal deletion mutants of FGFR2-IIIC

Five Prime Therapeutics, Inc. · Granted Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9175290

Compositions and methods for inhibiting expression of TMPRSS6 gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9169326

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic canc

PRECISION BIOLOGICS, INC. · Granted Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9169296

Expression and assembly of human group C rotavirus-like particles and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9162980

Anti-depression compounds

The Board of Regents of the University of Texas System · Granted Tue Oct 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9149450

Ischemia/reperfusion protection compositions and methods of using

Regents of the University of Minnesota · Granted Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9150847

Methods and compositions for regulation of transgene expression

Sangamo Biosciences, Inc. · Granted Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9149501

Methods of treating depression and other related diseases

Northwestern University · Granted Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9139634

Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activiti

The Regents of the University of California · Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9133461

Compositions and methods for inhibiting expression of the ALAS1 gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9133454

Method and medicament for inhibiting the expression of a given gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9115205

Plasmodium falciparum circumsporozoite vaccine gene optimization for soluble protein expre

The United States of America as represented by the Secretary of the Army · Granted Tue Aug 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted